Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1999 Nov;43(11):2783-6.
doi: 10.1128/AAC.43.11.2783.

In vitro activities of gatifloxacin, two other quinolones, and five nonquinolone antimicrobials against obligately anaerobic bacteria

R Schaumann  1 , G Ackermann, B Pless, M C Claros, A C Rodloff
Affiliations
Comparative Study

In vitro activities of gatifloxacin, two other quinolones, and five nonquinolone antimicrobials against obligately anaerobic bacteria

R Schaumann et al. Antimicrob Agents Chemother. 1999 Nov.

Abstract

The activity of the new fluoroquinolone gatifloxacin was compared with those of other quinolones and antimicrobial agents of other classes against 294 anaerobes by the broth microdilution technique. For all strains tested, gatifloxacin MICs at which 50 and 90% of the isolates were inhibited were 0.5 and 2 mg/liter, respectively, and were 3 to 4 dilution steps lower than, e.g., ciprofloxacin.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Aldridge K E, Ashcraft D, Bowman K A. Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobes. Antimicrob Agents Chemother. 1997;41:484–487. - PMC - PubMed
    1. Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J Antimicrob Chemother. 1997;40:639–651. - PubMed
    1. Claros M C, Citron D M, Hunt Gerardo S, Goldstein E J C, Schönian G, Montag T, Hampel B, Rodloff A C. Characterization of indole-negative Bacteroides fragilis group species with use of polymerase chain reaction fingerprinting and resistance profiles. Clin Infect Dis. 1996;23(Suppl. 1):S66–S72. - PubMed
    1. Claros, M. C., Y. Papke, N. Kleinkauf, D. Adler, D. M. Citron, S. Hunt-Gerardo, T. Montag, E. J. C. Goldstein, and A. C. Rodloff. Characteristics of Fusobacterium ulcerans, a new and unusual species compared to Fusobacterium varium and Fusobacterium mortiferum. Anaerobe, in press.
    1. Ednie L M, Jacobs M R, Appelbaum P C. Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms. Antimicrob Agents Chemother. 1998;42:2459–2462. - PMC - PubMed

Publication types

LinkOut - more resources